BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32321824)

  • 1. Host Cathelicidin Exacerbates Group B
    Patras KA; Coady A; Babu P; Shing SR; Ha AD; Rooholfada E; Brandt SL; Geriak M; Gallo RL; Nizet V
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32321824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.
    Tan CK; Carey AJ; Cui X; Webb RI; Ipe D; Crowley M; Cripps AW; Benjamin WH; Ulett KB; Schembri MA; Ulett GC
    Infect Immun; 2012 Sep; 80(9):3145-60. PubMed ID: 22733575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection.
    Kline KA; Schwartz DJ; Lewis WG; Hultgren SJ; Lewis AL
    Infect Immun; 2011 Sep; 79(9):3588-95. PubMed ID: 21690238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.
    Kline KA; Schwartz DJ; Gilbert NM; Hultgren SJ; Lewis AL
    Infect Immun; 2012 Dec; 80(12):4186-94. PubMed ID: 22988014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory leukocyte protease inhibitor protects against severe urinary tract infection in mice.
    Rosen AL; Lint MA; Voelker DH; Gilbert NM; Tomera CP; Santiago-Borges J; Wallace MA; Hannan TJ; Burnham C-AD; Hultgren SJ; Kau AL
    mBio; 2024 Feb; 15(2):e0255423. PubMed ID: 38270443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.
    Danka ES; Hunstad DA
    J Infect Dis; 2015 Apr; 211(7):1164-73. PubMed ID: 25336727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Age, but Not Parity Predisposes to Higher Bacteriuria Burdens Due to Streptococcus Urinary Tract Infection and Influences Bladder Cytokine Responses, Which Develop Independent of Tissue Bacterial Loads.
    Sullivan MJ; Carey AJ; Leclercq SY; Tan CK; Ulett GC
    PLoS One; 2016; 11(12):e0167732. PubMed ID: 27936166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections.
    Babikir IH; Abugroun EA; Bilal NE; Alghasham AA; Abdalla EE; Adam I
    BMC Infect Dis; 2018 Jan; 18(1):17. PubMed ID: 29310594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1alpha.
    Ulett GC; Webb RI; Ulett KB; Cui X; Benjamin WH; Crowley M; Schembri MA
    J Infect Dis; 2010 Mar; 201(6):866-70. PubMed ID: 20132033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonuclease 7 Shields the Kidney and Bladder from Invasive Uropathogenic
    Eichler T; Bender K; Murtha MJ; Schwartz L; Metheny J; Solden L; Jaggers RM; Bailey MT; Gupta S; Mosquera C; Ching C; La Perle K; Li B; Becknell B; Spencer JD
    J Am Soc Nephrol; 2019 Aug; 30(8):1385-1397. PubMed ID: 31239387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder.
    Hertting O; Holm Å; Lüthje P; Brauner H; Dyrdak R; Jonasson AF; Wiklund P; Chromek M; Brauner A
    PLoS One; 2010 Dec; 5(12):e15580. PubMed ID: 21179490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.
    Di Nardo A; Yamasaki K; Dorschner RA; Lai Y; Gallo RL
    J Immunol; 2008 Jun; 180(11):7565-73. PubMed ID: 18490758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections.
    Nielsen KL; Dynesen P; Larsen P; Jakobsen L; Andersen PS; Frimodt-Møller N
    Infect Immun; 2014 Apr; 82(4):1572-8. PubMed ID: 24452682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fungal Pathogen
    Shing SR; Ramos AR; Patras KA; Riestra AM; McCabe S; Nizet V; Coady A
    Front Cell Infect Microbiol; 2019; 9():437. PubMed ID: 31998657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.
    Patras KA; Ha AD; Rooholfada E; Olson J; Ramachandra Rao SP; Lin AE; Nizet V
    J Innate Immun; 2019; 11(6):481-495. PubMed ID: 31055580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction of chronic Escherichia coli urinary tract infection depends upon T cell-derived interleukin-17, a deficiency of which predisposes to flagella-driven bacterial persistence.
    Chamoun MN; Sullivan MJ; Goh KGK; Acharya D; Ipe DS; Katupitiya L; Gosling D; Peters KM; Sweet MJ; Sester DP; Schembri MA; Ulett GC
    FASEB J; 2020 Nov; 34(11):14572-14587. PubMed ID: 32901999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients.
    Mohanty S; Kamolvit W; Zambrana S; Gonzales E; Tovi J; Brismar K; Östenson CG; Brauner A
    J Mol Med (Berl); 2022 Jan; 100(1):101-113. PubMed ID: 34651203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection.
    Chromek M; Slamová Z; Bergman P; Kovács L; Podracká L; Ehrén I; Hökfelt T; Gudmundsson GH; Gallo RL; Agerberth B; Brauner A
    Nat Med; 2006 Jun; 12(6):636-41. PubMed ID: 16751768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.
    Lin AE; Beasley FC; Olson J; Keller N; Shalwitz RA; Hannan TJ; Hultgren SJ; Nizet V
    PLoS Pathog; 2015 Apr; 11(4):e1004818. PubMed ID: 25927232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary tract infections in children caused by uropathogenic strains of Escherichia coli and the role of the innate immune response mediated by the toll-like receptor 4 and antimicrobial peptide cathelicidin in their clinical course].
    Liptáková A; Podracká L; Siegfried L
    Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):72-7. PubMed ID: 17593804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.